Provided by Tiger Trade Technology Pte. Ltd.

Alamar Biosciences

25.91
-1.8600-6.70%
Post-market: 25.910.00000.00%16:26 EDT
Volume:954.24K
Turnover:24.96M
Market Cap:1.80B
PE:-36.19
High:28.07
Open:28.05
Low:25.37
Close:27.77
52wk High:39.61
52wk Low:18.85
Shares:69.31M
Float Shares:12.94M
Volume Ratio:1.20
T/O Rate:7.38%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7160
EPS(LYR):-2.5873
ROE:-33.57%
ROA:-13.53%
PB:5.74
PE(LYR):-10.01

Loading ...

Alamar Biosciences Launches the First Multiplexed Blood-based Immunoassay for eMTBR-Tau, One of the Most Important Biomarkers in Alzheimer’s Disease Research

GlobeNewswire
·
Jul 07

Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)

TIPRANKS
·
Jun 09

Alamar Biosciences initiated with an Outperform at Leerink

TIPRANKS
·
May 13

BofA Initiates Alamar Biosciences at Neutral With $27 Price Target

MT Newswires Live
·
May 12

Alamar Biosciences, Inc. : Bofa Global Research Initiates Coverage With Neutral Rating and Price Objective $27.00

THOMSON REUTERS
·
May 12

Stifel Initiates Alamar Biosciences at Buy With $28 Price Target

MT Newswires Live
·
May 12

Alamar Biosciences Initiated at Buy by Stifel

Dow Jones
·
May 12

Alamar Biosciences Inc : TD Cowen Initiates Coverage With Buy Rating; Price Target $30

THOMSON REUTERS
·
May 12

Alamar Biosciences Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $35

THOMSON REUTERS
·
May 12

Alamar Biosciences initiated with a Buy at TD Cowen

TIPRANKS
·
May 12

Alamar Biosciences initiated with an Overweight at JPMorgan

TIPRANKS
·
May 12

Alamar Biosciences initiated with a Buy at Stifel

TIPRANKS
·
May 12

U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis

Reuters
·
May 12

Alamar Biosciences Q1 Loss Widens, Revenue Rises

MT Newswires Live
·
May 08

Earnings Flash (ALMR) Alamar Biosciences Posts Q1 Net Loss $1.74 a Share

MT Newswires Live
·
May 08

Alamar Biosciences Q1 FY26 net loss widens to $21.3 million; revenue rises 99% to $26 million

Reuters
·
May 08

Alamar Biosciences Inc - Cash and Equivalents $69.5 Mln as of March 31, 2026

THOMSON REUTERS
·
May 08

Alamar Biosciences: Q1 EPS $-1.74

THOMSON REUTERS
·
May 08

Alamar Biosciences Inc - Q1 2026 Revenue Rises to $26.0 Mln

THOMSON REUTERS
·
May 08

Press Release: Alamar Biosciences Reports First Quarter 2026 Financial Results

Dow Jones
·
May 08